RU2180219C2 - Фармацевтическая композиция в виде таблетки и способ ее получения - Google Patents

Фармацевтическая композиция в виде таблетки и способ ее получения Download PDF

Info

Publication number
RU2180219C2
RU2180219C2 RU98113319/14A RU98113319A RU2180219C2 RU 2180219 C2 RU2180219 C2 RU 2180219C2 RU 98113319/14 A RU98113319/14 A RU 98113319/14A RU 98113319 A RU98113319 A RU 98113319A RU 2180219 C2 RU2180219 C2 RU 2180219C2
Authority
RU
Russia
Prior art keywords
tablets
mixture
water
crystalline cellulose
tablet
Prior art date
Application number
RU98113319/14A
Other languages
English (en)
Russian (ru)
Other versions
RU98113319A (ru
Inventor
Такеси ГОТО
Татсуя МЕНО
Original Assignee
Хисамицу Фармасьютикал Ко., Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хисамицу Фармасьютикал Ко., Инк. filed Critical Хисамицу Фармасьютикал Ко., Инк.
Publication of RU98113319A publication Critical patent/RU98113319A/ru
Application granted granted Critical
Publication of RU2180219C2 publication Critical patent/RU2180219C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
RU98113319/14A 1996-10-15 1997-10-15 Фармацевтическая композиция в виде таблетки и способ ее получения RU2180219C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8-293328 1996-10-15
JP29332896A JP4010585B2 (ja) 1996-10-15 1996-10-15 陰イオン交換樹脂を含有する錠剤

Publications (2)

Publication Number Publication Date
RU98113319A RU98113319A (ru) 2000-05-20
RU2180219C2 true RU2180219C2 (ru) 2002-03-10

Family

ID=17793408

Family Applications (1)

Application Number Title Priority Date Filing Date
RU98113319/14A RU2180219C2 (ru) 1996-10-15 1997-10-15 Фармацевтическая композиция в виде таблетки и способ ее получения

Country Status (16)

Country Link
US (1) US6197290B1 (US06197290-20010306-C00005.png)
EP (1) EP0873129B1 (US06197290-20010306-C00005.png)
JP (1) JP4010585B2 (US06197290-20010306-C00005.png)
KR (1) KR19990072020A (US06197290-20010306-C00005.png)
CN (1) CN1111413C (US06197290-20010306-C00005.png)
AT (1) ATE216248T1 (US06197290-20010306-C00005.png)
CA (1) CA2240402A1 (US06197290-20010306-C00005.png)
DE (1) DE69712033T2 (US06197290-20010306-C00005.png)
DK (1) DK0873129T3 (US06197290-20010306-C00005.png)
ES (1) ES2176792T3 (US06197290-20010306-C00005.png)
ID (1) ID21038A (US06197290-20010306-C00005.png)
PT (1) PT873129E (US06197290-20010306-C00005.png)
RU (1) RU2180219C2 (US06197290-20010306-C00005.png)
TW (1) TW528605B (US06197290-20010306-C00005.png)
UA (1) UA51686C2 (US06197290-20010306-C00005.png)
WO (1) WO1998016237A1 (US06197290-20010306-C00005.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2668499C2 (ru) * 2015-03-12 2018-10-01 Закрытое Акционерное Общество "Фармфирма "Сотекс" Фармацевтическая композиция в форме таблеток, покрытых кишечнорастворимой оболочкой, и способ ее получения

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69912389T2 (de) * 1998-08-05 2004-07-22 Hisamitsu Pharmaceutical Co., Inc., Tosu Verfahren zur herstellung von kationischem polymer
US6413394B1 (en) * 1999-07-08 2002-07-02 Thomas Y. Shen Disposable plate electrode with biological active film
ES2350307T3 (es) 2000-09-06 2011-01-20 Mitsubishi Tanabe Pharma Corporation Preparaciones granulares para administración oral.
EP1348442A4 (en) * 2000-11-28 2005-02-02 Mitsubishi Pharma Corp ANTI-OBESITY AGENTS AND DIET FOOD
CN1953756A (zh) 2004-03-26 2007-04-25 三菱制药株式会社 胰岛素抗性改善剂
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
ES2398477T3 (es) 2006-06-16 2013-03-19 Mitsubishi Tanabe Pharma Corporation Agente para la prevención y/o el tratamiento de glomerulopatía
US20090252794A1 (en) * 2006-08-09 2009-10-08 Tetsuya Suzuki Tablet
CN107233933A (zh) * 2017-05-09 2017-10-10 安徽皖东化工有限公司 一种水体净化用苯乙烯阴离子交换树脂的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI67483C (fi) * 1977-02-17 1985-04-10 Merck & Co Inc Foerfarande foer framstaellning av ett icke adhesivt friflytande farmakologiskt godtagbart gallsyrakomplexbildande adsorbatpreparat
SE445013B (sv) 1979-06-21 1986-05-26 Landstingens Inkopscentral Medel for att forebygga eller behandla infektioner hos menniskor och djur
JPH01172324A (ja) 1987-12-15 1989-07-07 Armour Internatl Co コレスチラミン組成物及びその製造法
US5178854A (en) 1988-03-24 1993-01-12 Taisho Pharmaceutical Co., Ltd. Cholesterol-lowering agents
EP0334673B1 (en) * 1988-03-24 1993-10-20 Taisho Pharmaceutical Co. Ltd Cholesterol-lowering agents
JPH02286621A (ja) 1989-04-26 1990-11-26 Mitsubishi Kasei Corp 経口コレステロール低下剤
DE4121127A1 (de) * 1991-06-26 1993-01-14 Rettenmaier & Soehne Gmbh & Co Hilfsstoff zur trockenen direkttablettierung und verfahren zur herstellung desselben
JP2712056B2 (ja) * 1992-01-14 1998-02-10 久光製薬株式会社 コレステロール低下剤
JP3552285B2 (ja) 1993-08-03 2004-08-11 三菱化学株式会社 経口コレステロール低下剤
TW438608B (en) 1995-08-02 2001-06-07 Hisamitsu Pharmaceutical Co A tablet containing anion exchange resin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2668499C2 (ru) * 2015-03-12 2018-10-01 Закрытое Акционерное Общество "Фармфирма "Сотекс" Фармацевтическая композиция в форме таблеток, покрытых кишечнорастворимой оболочкой, и способ ее получения

Also Published As

Publication number Publication date
AU4572697A (en) 1998-05-11
JP4010585B2 (ja) 2007-11-21
DE69712033D1 (de) 2002-05-23
WO1998016237A1 (en) 1998-04-23
AU723340B2 (en) 2000-08-24
ATE216248T1 (de) 2002-05-15
UA51686C2 (uk) 2002-12-16
EP0873129B1 (en) 2002-04-17
CA2240402A1 (en) 1998-04-23
TW528605B (en) 2003-04-21
EP0873129A1 (en) 1998-10-28
ID21038A (id) 1999-04-08
CN1204965A (zh) 1999-01-13
KR19990072020A (ko) 1999-09-27
DE69712033T2 (de) 2002-08-22
ES2176792T3 (es) 2002-12-01
PT873129E (pt) 2002-09-30
CN1111413C (zh) 2003-06-18
US6197290B1 (en) 2001-03-06
JPH10114661A (ja) 1998-05-06
DK0873129T3 (da) 2002-07-01

Similar Documents

Publication Publication Date Title
US6022533A (en) Tablets containing anion exchange resin
KR100348842B1 (ko) 염기성물질로안정화된약제학적조성물
US5413782A (en) Binding pharmaceuticals to ion exchange resins
RU2180219C2 (ru) Фармацевтическая композиция в виде таблетки и способ ее получения
HU190750B (en) Process for preparing resinates of 0-/2,6-dichloro-anilino/-phenyl-acetic acid
PT642785E (pt) Sistemas de hidrogel heterodisperso de libertacao sustida
JP2001502671A (ja) ＨＭＧ―ＣｏＡ還元酵素阻害剤フルバスタチンの徐放性医薬組成物
KR100240362B1 (ko) 콜레스티폴 하이드로클로라이드의 정제화
CA2055905C (en) Pharmaceutical composition comprising calcium polycarbophil
TW200305445A (en) Dosage forms for hygroscopic active ingredients
IE58246B1 (en) Theophylline sustained release formulation
JP2849047B2 (ja) ジクロフェナクナトリウム持続性製剤およびその製法
JP3963982B2 (ja) 陰イオン交換樹脂を含有する錠剤
CN113456607B (zh) 一种沙库巴曲缬沙坦钠单层渗透泵控释片及其制备方法
JPH08325145A (ja) 安定なイソプロピルアンチピリン含有製剤
AU723340C (en) Anion exchange resin-containing tablets
IL138950A (en) Stable compounds containing bosimandan and alginic acid
JP2021098671A (ja) レベチラセタム含有医薬組成物
JP4696210B2 (ja) イソソルビド‐５‐モノニトレートを有効成分とする徐放性錠剤及びその製造方法
CN108938584B (zh) 一种含VEGF受体抑制剂Tivozanib盐的片剂及其制备方法
CN113855672A (zh) 一种缬沙坦氨氯地平复方制剂的制备方法
CN115105511A (zh) 双氯芬酸钠米索前列醇片剂组合物及其制备方法
EP0614358A1 (en) Process and composition for the development of controlled release gemfibrozil dosage form